costs of glp 1 medications The cost manufacturing GLP-1 anti-obesity drugs is low As Interest in GLP-1 Drugs

For safety reasons some governments have banned some of these therapeutic agents as the potential for misuse was perceived to be high especially the parenteral use of glutathione for skin whitening practised in some Asian countries

People with diabetes, particularly severe diabetes, tend to lose less weight with GLP-1s than people without diabetes, so microdosing is less likely to be as effective, though their dose should only be increased as they tolerate it. George said that in her professional opinion, microdosing is a potential option for patients with smaller amounts of weight to lose or as a bridge to start, or wean off, regular GLP-1 medications

patients starting the medication compared with December 2023

This paper aims to identify the different stakeholder values in order to arrive at a value-based transition policy